Skip to main content
logo
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.3500
+0.0078 (2.28%)
Apr 28, 2026, 1:32 PM EST

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had revenue of $31.59M in the quarter ending December 31, 2025, with 119.92% growth. This brings the company's revenue in the last twelve months to $140.12M, up 100.18% year-over-year. In the fiscal year ending March 31, 2025, Elite Pharmaceuticals had annual revenue of $84.04M with 48.42% growth.

Revenue (ttm)
140.12M
Revenue Growth
+100.18%
P/S Ratio
2.66
Revenue / Employee
2.06M
Employees
68
Market Cap
372.76M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202584.04M27.42M48.42%
Mar 31, 202456.63M22.47M65.79%
Mar 31, 202334.16M1.89M5.87%
Mar 31, 202232.26M6.88M27.11%
Mar 31, 202125.38M7.39M41.05%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sofgen Pharma373.80M
Jushi Holdings262.91M
Glass House Brands181.98M
MariMed159.83M
Earth Science Tech34.87M
Radnostix13.07M
Growth Stalk Holdings583.34K
Kaya Holdings26.69K
Revenue Rankings

Elite Pharmaceuticals News

More News